NCT02159313View on ClinicalTrials.gov

Relative Bioavailability Study

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

January 31, 2015

Conditions
Healthy Volunteers
Interventions
DRUG

Riociguat(Adempas,BAY63-2521)

Single dose of a whole 2.5 mg riociguat tablet

Trial Locations (1)

41061

Mönchengladbach

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY